Short Interest in ClearPoint Neuro Surges 29% in March

Got story updates? Submit your updates here. ›

ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw a significant increase in short interest during March, with the number of shares sold short rising 29% to 4,288,498 as of March 13th. This represents around 15.4% of the company's total outstanding stock. The short-interest ratio, based on the stock's average daily trading volume, is currently 2.9 days.

Why it matters

The rise in short interest could indicate growing investor skepticism about ClearPoint Neuro's prospects, as short sellers bet on the stock price declining. This could put pressure on the company's share price in the near term, especially if the short position continues to grow.

The details

ClearPoint Neuro is a medical technology company that specializes in the development and commercialization of an MRI-guided therapy platform for minimally invasive neurosurgical procedures. The company's flagship ClearPoint® SmartFrame™ system enables surgeons to perform accurate and efficient intracranial interventions by providing real-time magnetic resonance imaging feedback.

• As of March 13th, 2026, there was short interest totaling 4,288,498 shares in ClearPoint Neuro.
• This represents a 29.0% increase from the February 26th total of 3,325,107 shares.

What’s next

Investors will be closely watching to see if the short interest in ClearPoint Neuro continues to rise, as this could put further downward pressure on the stock price. The company's upcoming financial results and any updates on its product development and commercialization efforts will also be closely monitored by the market.